Although semaglutide is the generic name, most markets do not have approved generic counterparts
Retatrutide is a medication still in clinical trials that might surpass these popular medications in weight-loss effectiveness
Patients discontinuing semaglutide should work with healthcare providers to implement a structured discontinuation plan including nutrition guidance, regular physical activity (particularly resistance training to preserve lean muscle mass), and behavioral strategies to support weight maintenance and metabolic health
My advice is to make sure patients gather all their documentation ahead of time, communicate clearly with their provider about whats needed, and reach out to Novo Nordisks helpline for help if they have questions. To learn more about the PAP, visit the Novo Nordisk website or call their toll-free helpline at 1-866-310-7549
Drumm C, Clowry J, Healy ML, Wynne B
This review underscores the necessity of early recognition, accurate diagnosis, and tailored interventions to mitigate complications and enhance patient outcomes